Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Organizations
Organizations
Verenium
Products 1 to 5 of 5
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Detalzym GA L-E5 Glucoamylase
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
Germany
+
USA
+
China
+
Japan
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/12/26 15:16 (6 years ago)
Known funding amount:
2,147,483,647 EUR
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
No longer on the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
Eradicake Alpha-Amylase
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Mexico
+
Canada
+
Germany
+
Singapore
+
Brazil
+
China
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/12/26 15:23 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
Fuelzyme 650 Alpha-amylase
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Europe
+
Asia
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/05/15 15:45 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
Pyrolase Cellulase
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Canada
+
Mexico
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/02/13 15:37 (6 years ago)
Known funding amount:
2,147,483,647 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Open Release
Source:
SynBio Database
Trading symbol:
BASF SE
(XETRA)
Value chain stage:
Finished Product
Xylathin Xylanase (#1)
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/05/15 15:44 (6 years ago)
Known funding amount:
2,147,483,647 EUR
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
